The global hemostats market is projected to hit $5.32 billion by 2032, growing at a CAGR of 6.9%. This growth is fueled by rising surgical volumes, technological innovations, and increasing healthcare investments. Absorbable hemostats and minimally invasive solutions dominate market demand.
